Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma

Published:2022-11 Issue: Volume:548 Page:215864
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wu Liangliang,Ge Yi,Yuan Yudong,Li Hui,Sun Huizhi,Xu Chao,Wang Yifei,Zhao Tiansuo,Wang Xiuchao,Liu Jing,Gao Song,Chang Antao,Hao Jihui,Huang Chongbiao

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. Cancer statistics, 2022;Siegel;CA A Cancer J. Clin.,2022

2. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data;Bengtsson;Sci. Rep.,2020

3. Metastatic pancreatic cancer: American society of clinical oncology clinical practice guideline;Sohal;J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol.,2016

4. Gemcitabine: a review of chemoresistance in pancreatic cancer;Sarvepalli;Crit. Rev. Oncog.,2019

5. Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review;Koltai;Cancers,2022

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma;Cancer Letters;2024-08

2. Targeting IL-6/STAT3 signaling abrogates EGFR-TKI resistance through inhibiting Beclin-1 dependent autophagy in HNSCC;Cancer Letters;2024-04

3. Uncovering the bookshelves of CRISPR-based libraries: Advances and applications in cancer studies;Critical Reviews in Oncology/Hematology;2024-04

4. Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma;Frontiers in Pharmacology;2024-03-20

5. Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges;Frontiers of Medicine;2023-12-27